Etretinate treatment of the nevoid basal cell carcinoma syndrome. Therapeutic and chemopreventive effect.
A patient suffering from the nevoid basal cell carcinoma syndrome, in whom various surgical and conservative treatment modalities had been tried previously, was placed on oral etretinate therapy. A therapeutic effect of the etretinate on existing basal cell carcinomas and a prophylactic effect in inhibiting new tumor formation were well demonstrated during the 13-month period of treatment.
Hodak
E
E
Department of Dermatology, Beilinson Medical Center, Petah Tiqva, Israel.
Ginzburg
A
A
David
M
M
Sandbank
M
M
D001478:Basal Cell Nevus Syndrome / Q000188:drug therapy* / Q000517:prevention & control; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D005050:Etretinate / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged
D005050:Etretinate